Refine your search with filters

All-Materials All
Congress-AbstractsCongress Abstracts
Tools-SkillsTools & Skills
PublicationsPublications
Congress-SlidesCongress Presentations
Videos-PodcastsVideos & Podcasts

Quicksearch

P188: Crohn's disease of the terminal Ileum: PET-MRE results correlate well with biomarkersECCO '17 Barcelona
Year: 2017
Authors:

Leibovitzh H.1,2, Avni-Biron I.1,2, Lichtenstein L.1,2, Groshar D.2,3, Bernstine H.2,3, Domachevsky L.2,3, Fraser G.M.1,2, Ben-Bassat O.*1,2

1Rabin medical center, The Gastroenterology Dept, Petach tikva, Israel 2Tel Aviv University, Sackler School of Medicine, Tel Aviv, Israel 3Rabin medical center, Department of Nuclear Medicine, Petach tikva, Israel

P189: Serum neutrophil gelatinase-associated lipocalin correlates with Mayo Clinic score in ulcerative colitis but fails to predict activity in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Budzyńska A., Nowakowska-Duława E., Gawron-Kiszka M., Śpiewak J., Hartleb M.

Medical University of Silesia, Department of Gastroenterology & Hepatology, Katowice, Poland

P190: Comparison of two endoscopic scores of inflammatory activity in small-bowel Crohn's disease and its correlation with clinical activity and biomarkersECCO '17 Barcelona
Year: 2017
Authors:

Ponte A., Pinho R., Rodrigues A., Silva J., Rodrigues J., Sousa M., Silva A.P., Alberto L., Carvalho J.

Centro Hospitalar Vila Nova de Gaia/Espinho, Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova Gaia, Portugal

P191: The robotic surgery in the treatment of Crohn's disease: our experienceECCO '17 Barcelona
Year: 2017
Authors:

Marino M.V., Salamone G., Gulotta G.

University of Palermo, Emergency and General Surgery, Palermo, Italy

P192: Heartburn in Crohn's disease is associated with increased disease activity, poor sleep quality and prior ileocecectomyECCO '17 Barcelona
Year: 2017
Authors:

Sofia M.A., Lipowska A.M., Perez E.Y., Zmeter N., Kavitt R.T., Rubin D.T.

The University of Chicago, Department of Medicine - Section of Gastroenterology, Hepatology, and Nutrition, Chicago, United States

P193: Faecal calprotectin differentially predicts postoperative endoscopic recurrence in Crohn's disease according to therapy. A prospective multicenter studyECCO '17 Barcelona
Year: 2017
Authors:

Verdejo Gil C.*1, Lucendo Villarin A.J.2, Hervías Cruz D.3, Roncero García-Escribano Ó.4, Bouhmidi A.5, Salmoral Luque R.1, Angueira T.2, Rincόn L.6, Salueña I.5, Lorente Poyatos R.1

1Hospital General Universitario de Ciudad Real, Gastroenterology, Ciudad Real, Spain 2Hospital General de Tomelloso, Gastroenterology, Tomelloso, Spain 3Hospital Virgen de Altagracia, Gastroenterology, Manzanares, Spain 4Hospital General La Mancha Centro, Gastroenterology, Alcázar de San Juan, Spain 5Hospital Santa Bárbara, Gastroenterology, Puertollano, Spain 6Hospital General Universitario de Ciudad Real, Clinical Laboratory, Ciudad Real, Spain

P194: Anti-TNFα treatment following surgical resection for Crohn's disease is effective despite previous pharmacodynamic failureECCO '17 Barcelona
Year: 2017
Authors:

Assa A.*1, Bronsky J.2, Kolho K.-L.3, Zarubova K.4, de Meij T.5, Ledder O.6, Sladek M.7, van Biervliet S.8, Strisciuglio C.9, Shamir R.10

1Schneider Children's medical Center, Gastroenterology, Nutrition and Liver Diseases, Petach Tikva, Israel 2Charles University and University Hospital Motol, prague, Czech Republic 3University of Helsinki, Helsinki, Finland 4Charles University and University Hospital Motol, Prague, Czech Republic 5VU University Medical Center, Amsterdam, Netherlands 6Shaare Zedek Medical Center, Jerusalem, Israel 7Polish-American Children's Hospital, Krakow, Poland 8Ghent University Hospital, Ghent, Belgium 9University of Naples, Naples, Italy 10Schneider Children's medical Center, Petach Tikva, Israel

P195: The utility of fecal microRNAs in the diagnosis of inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Yi F.

Second affiliated hospital of Nanchang University, Department of Oncology, Nanchang, China

P196: Patients with ulcerative colitis (UC) and concomitant primary sclerosing cholangitis (PSC) have more subclinical endoscopic and histologic disease activity in the right colon compared to UC patients without PSCECCO '17 Barcelona
Year: 2017
Authors:

Krugliak Cleveland N.1, Rubin D.1, Meckel K.1, Tran A.1, Aelvoet A.1, Gonsalves A.1, Gaetano J.N.2, Williams K.1, Jabri B.1, Wroblewski K.3, Pekow J.*1

1University of Chicago Medicine, Inflammatory Bowel Disease Center, Chicago, United States 2Northwestern University Feinberg School of Medicine, Chicago, United States 3University of Chicago, Department of Public Health Science, Chicago, United States

P197: Improved maternal and neonatal outcomes in a clinic dedicated to pregnant patients with inflammatory bowel diseaseECCO '17 Barcelona
Year: 2017
Authors:

Shitrit A.B.-G.*1, Koslowsky B.1, Livovsky D.M.1, Goldin E.1, Mazuz B.1, Granovsky-Grisaru S.2

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel 2Shaare Zedek Medical Center, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Jerusalem, Israel

P198: Dipeptidyl peptidase 4: a strong predictive marker of disease activity and treatment escalation in inflammatory bowel diseasesECCO '17 Barcelona
Year: 2017
Authors:

Pinto-Lopes P.*1,2, Afonso J.1, Macedo G.3, Magro F.1,3

1Faculty of Medicine, University of Porto, Department of Biomedicine – Pharmacology and Therapeutics Unit, Porto, Portugal 2Faculty of Medicine, University of Porto and Centro Hospitalar São João, Internal Medicine Department, Porto, Portugal 3Faculty of Medicine, University of Porto and Centro Hospitalar São João, Gastroenterology Department, Porto, Portugal

P199: PET/MR for evaluating subclinical inflammation of ulcerative colitis in remissionECCO '17 Barcelona
Year: 2017
Authors:

Wei S.C.*1, Shih I.-L.2, Lin B.-R.3, Yen R.-F.4, Chang Y.-C.2, Wong J.-M.1

1National Taiwan University Hospital and College of Medicine, Department of Internal Medicine, Taipei, Taiwan 2National Taiwan University Hospital and College of Medicine, Department of Medical Image, Taipei, Taiwan 3National Taiwan University Hospital and College of Medicine, Department of Surgery, Taipei, Taiwan 4National Taiwan University Hospital and College of Medicine, Department of Nuclear Medicine, Taipei, Taiwan

P200: Faecal calprotectin as a marker of relapse in inflammatory bowel disease – its place in the management algorithm and cost effectiveness in PolandECCO '17 Barcelona
Year: 2017
Authors:

Petryszyn P.*1, Wieckowska N.2, Trznadel A.2, Ekk-Cierniakowski P.3, Staniak A.1, Dudkowiak R.4, Piotrowski P.5

1Wroclaw Medical University, Clin Pharmacology, Wroclaw, Poland 2Wroclaw Medical University, Wroclaw, Poland 3Warsaw School of Economics, Warsawa, Poland 4Wroclaw Medical University, Gastroenterology and Hepatology, Wroclaw, Poland 5Wroclaw Medical University, Psychiatry, Wroclaw, Poland

P201: A faecal bacterial markers correlates with Calprotectin for IBD activity monitoring?ECCO '17 Barcelona
Year: 2017
Authors:

Amoedo J.*1,2, Serra-Pagès M.2, Serrano M.2, Bahí A.3, Malagόn M.3, Gilabert P.4, Guardiola J.4, Busquets D.3, Garcia-Gil J.1,2, Aldeguer X.3

1Universitat de Girona, Microbiologia, Girona, Spain 2GoodGut SL, Girona, Spain 3Institut de Investigaciό Biomèdica de Girona, Girona, Spain 4Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain

P202: Diagnosis of inflammatory bowel disease in asymptomatic subjects: disease characteristics, natural history and treatment requirementsECCO '17 Barcelona
Year: 2017
Authors:

Rodríguez-Lago I.*1, Merino O.2, Azagra I.3, Maiz A.4, Zapata E.5, Higuera R.6, Fernández-Calderόn M.7, Iriarte A.8, Arreba P.9, Carrascosa J.10, Montalvo I.11, Portillo I.12, Aguirre U.13,14, Cabriada J.L.1 IBD Study Group of the Basque–Navarre Society of Gastrointestinal Diseases, Pais Vasco-Navarra, Spain1,2,3,4,5,6,7,8,9,10,11

1Hospital de Galdakao, Gastroenterology, Galdakao, Spain 2Hospital Universitario de Cruces, Gastroenterology, Bilbao, Spain 3Hospital Universitario de Araba, Gastroenterology, Vitoria, Spain 4Hospital Donostia, Gastroenterology, Donostia, Spain 5Hospital de Mendaro, Gastroenterology, Mendaro, Spain 6Hospital de San Eloy, Gastroenterology, Bilbao, Spain 7Hospital de Mondragόn - Alto Deba, Gastroenterology, Mondragόn, Spain 8Hospital Comarcal del Bidasoa, Gastroenterology, Hondarribia, Spain 9Hospital Universitario de Basurto, Gastroenterology, Bilbao, Spain 10Hospital de Zumárraga, Gastroenterology, Zumárraga, Spain 11Onkologikoa, Gastroenterology, Donostia, Spain 12Basque Country Health Service, Colorectal cancer screening programme, Bilbao, Spain 13Hospital de Galdakao, Research Unit, Galdakao, Spain 14Health Services Research on Chronic Patients Network (REDISSEC), Galdakao, Spain

P203: Factors associated with restless legs syndrome in patients with ulcerative colitis: a study in a tertiary care center in RomaniaECCO '17 Barcelona
Year: 2017
Authors:

Popa R.C.*1, Savin A.1, Ungureanu I.1, Gavrilescu O.1,2, Dranga M.1,2, Chiosa A.M.1, Jigaranu O.1, Popa I.1, Mihai C.1,2, Cijevschi-Prelipcean C.1,2

1Gastroenterology and Hepatology Institute, Iasi, Romania 2University Of Medicine And Pharmacy, Gr. T. Popa, Department of Gastroenterology, Iasi, Romania

P204: Lipid profile in inflammatory bowel disease under maintenance wih anti-TNF: a prospective longitudinal cohort studyECCO '17 Barcelona
Year: 2017
Authors:

Ferreiro R., Lopez-Diaz J., Lorenzo A., Dominguez-Munoz J.E., Barreiro-de Acosta M.

University Hospital Santiago de Compostela, Gastroenterology, Santiago, Spain

P205: A telemanagement system web in patients with complex inflammatory bowel disease: design and implementation of a randomized clinical trialECCO '17 Barcelona
Year: 2017
Authors:

Aguas M.*1,2, Del Hoyo J.1, Muñoz D.1, Faubel R.3,4, Barrios A.1, Navarro B.1, Bastida G.1,2, Valdivieso B.5, Nos P.1,2

1La Fe University and Politechnic Hospital, Gastroenterology, Valencia, Spain 2CIBEREHD, Networked Biomedical Research Center for Hepatic and Digestive Diseases, Valencia, Spain 3Joint Research Unit in Biomedical Engineering - eRPSS (ICT applied to healthcare process re-engineering) IIS La Fe-UPV, Valencia, Spain 4Health Services Research on Chronic Patients Network (REDISSEC), Valencia, Spain 5La Fe University and Politechnic Hospital, Telemedicine Unit, Valencia, Spain

P206: Celiac disease and inflammatory bowel disease, a rare associationECCO '17 Barcelona
Year: 2017
Authors:

Boutaleb A.*1, Saoula H.1, Aissaoui M.1, Hamidouche D.1, Aissat Y.1, Mahiou H.1, Osmane R.1, Zmiri Y.1, Mitiche A.1, Nakmouche M.1, Hamchaoui F.2

1CHU of Bab El Oued, Gastroenterology, Algiers, Algeria 2CHU of Bab El Oued, Epidemiology, Algiers, Algeria

P207: Prevalence and characteristics of Romanian patients with upper GI tract involvement in Crohn's diseaseECCO '17 Barcelona
Year: 2017
Authors:

Dimitriu A., Ichim S., Cojocaru M., Gheorghe C., Diculescu M., Iacob R., Gheorghe L.

Clinical Institute Fundeni, Department of Digestive Diseases and Liver Transplantation, Bucharest, Romania